Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Oct;13(5):289-96.
doi: 10.1007/s11904-016-0330-z.

Metabolic Complications and Glucose Metabolism in HIV Infection: A Review of the Evidence

Amanda L Willig  1 , Edgar Turner Overton  2
Affiliations
Review

Metabolic Complications and Glucose Metabolism in HIV Infection: A Review of the Evidence

Amanda L Willig et al. Curr HIV/AIDS Rep. 2016 Oct.

Abstract

HIV infection and antiretroviral therapy (ART) use are associated with perturbations in glucose and lipid metabolism. Increasing incidence of diabetes, cardiovascular disease, and obesity highlights the need for early identification and treatment of metabolic dysfunction. Newer ART regimens are less toxic for cellular function and metabolism but have failed to completely eliminate metabolic dysfunction with HIV infection. Additional factors, including viral-host interactions, diet, physical activity, non-ART medications, and aging may further contribute to metabolic disease risk in the HIV setting. We summarize the recent literature regarding the impact on metabolic function of HIV infection, ART, and pharmaceutical or lifestyle prescriptions.

Keywords: ART; Adipose tissue; Complications in HIV infection; Fat; Glucose; HIV; Inflammation; Metabolism.

PubMed Disclaimer

References

    1. Muyanja D, Muzoora C, Muyingo A, Muyindike W, Siedner MJ. High Prevalence of Metabolic Syndrome and Cardiovascular Disease Risk Among People with HIV on Stable ART in Southwestern Uganda. AIDS patient care and STDs. 2016;30(1):4–10. - PMC - PubMed
    1. Nguyen KA, Peer N, Mills EJ, Kengne AP. A Meta-Analysis of the Metabolic Syndrome Prevalence in the Global HIV-Infected Population. PloS one. 2016;11(3):e0150970. - PMC - PubMed
    1. Schulte-Hermann K, Schalk H, Haider B, Hutterer J, Gmeinhart B, Pichler K, et al. Impaired lipid profile and insulin resistance in a cohort of Austrian HIV patients. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2016;22(4):248–53. - PubMed
    1. Mondy K, Overton ET, Grubb J, Tong S, Seyfried W, Powderly W, et al. Metabolic syndrome in HIV-infected patients from an urban, midwestern US outpatient population. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2007;44(5):726–34. - PMC - PubMed
    1. Araujo S, Banon S, Machuca I, Moreno A, Perez-Elias MJ, Casado JL. Prevalence of insulin resistance and risk of diabetes mellitus in HIV-infected patients receiving current antiretroviral drugs. European journal of endocrinology / European Federation of Endocrine Societies. 2014;171(5):545–54. - PubMed

MeSH terms

LinkOut - more resources